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INTRODUCTION
Vascular prosthetic graft infections (VPGIs) are well 
known for their serious implications in limb salvage rate, 
patient mortality, and health-care costs.1–4 The incidence 
of such infections ranges from 1% to 6%, statistics un-
changed over the past 15 years.5–8 The most common site 
for VPGI is the groin, most likely due to the high com-
mensal and pathologic bacterial load within the immedi-
ate vicinity to the perineum and the close proximity of the 
prostheses to the skin and lymphatic vessels at risk of tran-
section during surgery.1,9 Vascular prosthetics implanted 
in this area have been associated with a mortality rate of 
as high as 25%,10 and recurrence of infection occurs in 
up to 35% of patients, even those subjected to extensive 
debridement and muscle flap transposition.11
At present, a number of accepted treatment options 
are used to manage an infected groin wound with an ex-
posed vascular prosthetic graft. Traditional radical inter-
ventions focusing on the removal of the graft, extensive 
debridement, and vascular reconstructions are all proce-
dures associated with mortality rates of 10–60% and limb 
loss as great as 80%.2,3,11,12 There is a growing use of pros-
thesis-sparing interventions advocated, albeit in specific 
patients, namely systemic and local antibiotic infiltration, 
catheter irrigation and drainage, muscle flap transposi-
tion, and negative wound pressure therapy (NWPT), in 
variable combinations with one another.1,10,13–16 Although 
NWPT has shown to be a valuable treatment option, there 
are situations where stable wound coverage cannot be ob-
tained with such a modality alone. In a case report from 
1979, Hill et al.17 used a combination of sartorius muscle 
(SM) flap and tensor fascia lata (TFL) musculocutaneous 
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flap to cover the femoral vessels and close a groin wound 
after tumor resection. To our knowledge, there are no 
publications that report on this flap combination in the 
treatment of groin infections following arterial revascu-
larization procedures. With their rich vascularity, muscle 
flaps enhance wound healing and assist in the elimination 
of residual infection.18 In contrast to fasciocutaneous flaps, 
muscle flaps easily fill dead space. The SM flap transposi-
tion is a well-established technique used in the treatment 
of VPGI in the groin.1,3,4 One of the drawbacks of the SM 
flap is its relative small volume. The SM flap may therefore 
be insufficient to provide stable wound coverage of a large 
remaining groin defect. The TFL flap transposition is a 
well-established technique for the closure of groin defects 
but not for the coverage of an infected and exposed vascu-
lar prosthetic graft.
In this article, we report our experience with the com-
bination of a SM flap and TFL flap in the treatment of an 
infected and exposed vascular prosthetic graft with a large 
groin defect.
MATERIALS AND METHODS
This study reports on 5 patients with an infected groin 
wound and exposed vascular prosthetic graft. Patient data 
are summarized in Table 1. All patients were classified ac-
cording to the American Association of Anesthesiologists 
(ASA) as ASA III and had surgical histories including sever-
al operations involving debridement. Antibiotic treatment 
was based on wound cultures taken at the time of debride-
ment. Three patients had also received NWPT using the 
Vacuum-assisted Closure System (VAC, KCI Medical, San 
Antonio, Tex.). Patients were referred to the Department 
of Plastic Surgery as it was unlikely to obtain stable wound 
coverage over the prosthetic graft with standard proce-
dures.
Preoperative Planning
With the patient in the supine position, a line was 
drawn from the anterior superior iliac spine (ASIS) to the 
lateral aspect of the patella. The vascular pedicle supply-
ing the TFL flap, the transverse branch of the lateral cir-
cumflex femoral artery, can be found 8–10 cm below the 
ASIS on this line and was identified using hand-held Dop-
pler. The size of the flap must be of an adequate width 
and length to allow a tension-free closure of the groin 
defect after transposition. However, the cutaneous distal 
one-third of the TFL flap has an unreliable perfusion, a 
fact that must be taken into account when planning the 
size of the flap.
Surgical Procedure
Under general anesthesia and with the patient in su-
pine position, wound debridement was performed and 
cultures for microbiology were taken. The SM was iden-
tified and released from the ASIS, keeping a part of the 
tendon still attached to the muscle. The muscle was mo-
bilized distally until it allowed for transposition without 
tension over the exposed vascular graft being careful to 
rotate in on its medial border to preserve its pedicle blood 
supply. A vacuum drain was placed over the vascular graft. 
The muscle and its fascia were sutured to the tissue sur-
rounding the vascular graft with resorbable sutures. The 
TFL flap was harvested in a subfascial plane from distal to 
proximal and the pedicle was identified. The skin bridge 
between the groin defect and TFL donor site was incised 
to allow the TFL flap to be transposed over the SM and to 
close the remaining groin defect. The wound was closed 
in layers over a suction drain. NPWT was used during the 
first 5 postoperative days to stabilize the lateral suture line 
following transposition of the TFL flap.
RESULTS
In all 5 patients, mean age 65 years (range, 49–74 
years), the combined flap procedure resulted in stable 
wound coverage. The mean follow-up was 46 months 
(range, 15–79 months), with only 1 patient (case 2) hav-
ing a recurrence at 15 months. Only 1 patient (case 3) had 
a small tip necrosis of the TFL flap that could be treated 
with a wound revision in local anesthesia.
Case Presentation (Case 1)
A 49-year-old man with a history of arteriosclerosis, 
claudicatio intermittens, and cardiac transplantation had 
been operated on with an aorta bifemoral bypass. Six 
weeks after the bypass procedure, he developed an occlu-
sion of the graft in the right groin. After an embolectomy, 
the wound was treated with VAC system for 7 days. The 
patient was referred to the Department of Plastic Surgery 
to obtain stable coverage over the exposed vascular pros-
thetic graft (Fig. 1A). Wound cultures revealed Candida 
albicans. In this immune-suppressed patient, a TFL flap of 
18 × 5 cm was designed to obtain stable wound coverage of 
the groin wound and to contribute to lymphatic drainage 
of the groin region (Fig. 1B). Initially, the skin defect mea-
sured 11 × 4 cm and after debridement 12 × 8 cm. Transpo-
Table 1. Patient Data









1 49 M III Y CA Dacron ABF bypass 7 79 Good
2 74 M III Y SE Dacron IF bypass 0 15 Recurrence
3 66 M III Y CA Goretex AFF bypass 0 33 Good
4 61 F III Y SA/SE Goretex FF crossover 6 58 Good
5 73 F III Y SA/SC Dacron ABF bypass 6 43 Good
ASA, American Association of Anesthesiologists; ABF, aorto-bifemoral bypass; AFF, aorto-femoro-femoral; BMI, body mass index, kg/m2; CA, Candida albicans; FF, 
femoro-femoral; IF, iliaco-femoral; MB, microbiology; SA, Staphylococcus aureus; SE, S. epidermis; SC, Streptococcus.
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sition of the SM over the graft (Fig. 1C) was followed by a 
TFL transposition (Fig. 1D). During the 79 months follow-
up, there were no signs of wound problems in the groin.
Case Presentation (Case 2)
A 73-year-old male, with a history of chronic obstruc-
tive lung disease and surgery for an abdominal aneurysm, 
developed a wound in the right groin with an infected and 
exposed Dacron graft after a bypass operation for an aneu-
rysm in the iliac communis artery (Fig. 2A). Following de-
bridement, the vascular graft was covered with a combined 
SM flap and TFL flap (Fig. 2B). After 15 months, he was 
readmitted, presenting with the graft protruding along-
side the SM and TFL flap through the skin (Fig. 2C). Clini-
cal examination and CT scan investigation revealed a kink 
in the elongated graft directed toward the skin (Fig. 2D). 
The vascular graft was shortened, and both the SM and 
TFL flap could be used again for coverage. However, after 
4 months, the graft had to be removed due to a new recur-
rence. A bypass from the left internal iliac artery to the 
right superficial and deep femoral artery was successfully 
created and both the SM and TFL flaps were again used to 
cover the arterial reconstruction in the groin. The patient 
died after 4 years from bacterial pneumonia.
DISCUSSION
With an increasing number of vascular graft proce-
dures being performed each year, the incidence of pros-
thetic graft infections has remained 1–6%,1,5–8 with some 
series reporting incidences closer to 5–10%.5
One of the newest modalities in graft preserving in-
terventions is the use of NWPT. Its noninvasive nature 
makes it a reasonable therapeutic option to consider be-
fore more drastic measures are attempted.10,11,15,19,20 It has 
been reported that the use of NWPT without the utiliza-
tion of muscle flap transposition has resulted in a success 
rate of 75%.21 There is, however, controversy with regard 
to the effects of NWPT that must be noted. Mouës et al.21 
and Weed et al.22 found that bacterial count was not sig-
nificantly affected with the use of NWPT; this results in 
direct contrast with the series by Pinocy et al.10 and Mo-
rykwas et al.23 Despite these inconsistencies, it must be 
said that without the use of antimicrobials, NWPT has a 
similar effect on bacterial load as conventional  therapies.18 
There have been a few drawbacks reported related to 
NWPT. Kotsis and Lioupis19 and Demaria et al.24 noted a 
case of deep vein thrombosis at the application site that 
required treatment with anticoagulants and discontinua-
Fig. 1. a, exposed graft prosthesis. B, tFl flap design. c, SM flap transposition. D, end result.
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tion of NWPT. In the presence of an exposed anastomo-
sis, there have been reports of disrupted sutures, eroded 
vasculature, and arterial bleeding25,26; however, Mayer et 
al.27 reported on the use of NWPT directly adjacent to the 
prosthesis without resulting in complications and with a 
100% success rate and no recurrent infection. Svensson 
et al.15 reported a higher risk of amputation and death in 
persistent VPGI managed with NWPT. Generally, hospital 
admission time is increased in those with NWPT devices 
and the numerous operations to change the device repeat-
edly exposing patients to detrimental results like bleeding 
and reinfection. Although numerous series have advocat-
ed the use of NWPT in place of other modalities under 
certain circumstances,10,11,18,26 there are times when such 
an approach fails and other therapies must be sought.11,28
In 3 of our 5 patients, NWPT was used. The defects 
following NWPT in these patients were too large to be 
closed by secondary intention. Wide undermining would 
have caused impaired circulation of the skin flaps and an 
unacceptable high risk of wound rupture at a suture line 
positioned right over the prosthetic graft. However, we 
observed that NWPT had reduced the complex 3-dimen-
sionality of the wounds. The wound surfaces became more 
uniform, which allowed for a better contact with a well-vas-
cularized flap surface area. In the other 2 patients, the ex-
posed vascular prosthetic graft was positioned at skin level 
and was surrounded by skin and subcutaneous tissue of in-
ferior quality. In all 5 patients, a muscle flap transposition 
was required to obtain stable wound coverage over the ex-
posed vascular prosthesis. However, the remaining wound 
defects were too large to be closed by skin approximation, 
even after undermining. Coverage of the remaining defect 
with a skin graft has a significant disadvantage as a skin 
graft is far less elastic and stable compared with normal 
skin, which adapts easily to the movements in the groin.
The use of a variety of different muscle flaps has been 
advocated in a number of publications.1,3,4,12–14,17,29–31 The 
advantages of muscle flaps are numerous and include in-
creased blood supply to the operated area, bringing with 
it oxygen, nutrients, leukocytes, and systemic antibiot-
ics.4 The dead space left after extensive debridement of 
necrotic tissue can be filled by the patient’s own tissue, 
reducing the risk for potential complications and recur-
rent infections.30 In the groin, a number of muscle flaps 
have been described for the purpose of filling inguinal 
defects and covering the exposed vascular graft. The SM 
Fig. 2. a, Protrusion of the prosthesis through the skin. B, Result at 10 months after reconstruction. c, Recurrence at 15 months. D, 
computer tomography scan with kink in prosthesis.
 Zoepke and de Weerd • Treatment of Vascular Prosthetic Graft Infection
5
flap is the most common muscle flap used due to its acces-
sibility, retention of its shape, and ease of transposition.32 
Although many advocate its use, there is some hesitancy 
associated with its use in conjunction with vasculopathy 
of the superficial femoral artery.24 There are conflicting 
data with regard to the muscle’s arterial supply; Mathes 
and Nahai33 defined it as a type 4 segmental circulatory 
pattern dependent on the superficial femoral artery, in 
comparison to Ramasastry et al.34 who described its pri-
mary blood supply from the circumflex femoral vessels of 
the deep femoral artery. Those who support the notion 
of a type 4 segmental supply remain cautious using the 
muscle in circumstances where the superficial femoral ves-
sel is compromised. However, in a study by Töpel et al.,13 a 
sample group of 53 patients with 56 SM flap transpositions 
were observed for flap viability, 23 of which had patent su-
perficial femoral arteries and 33 were occluded. The deep 
femoral artery was classified as patent in all 56 cases. After 
an average follow-up time of 6.4 months, 54 viable flaps 
were documented. Much like Ramasastry et al.,34 Töpel et 
al.13 proposed that the patency of the superior femoral ar-
tery has little to do with flap viability, provided the deep 
femoral artery remains open and undiseased. In all the 5 
of our patients, a viable SM flap could be harvested.
A con of using the SM in isolation is its size and in-
ability to fill larger groin defects.12 With this problem in 
mind, the use of the TFL muscle flap can be used in con-
junction to provide a second layer of tissue overlying the 
defect. The TFL muscle originates lateral to the SM on the 
anterolateral aspect of the iliac crest. It derives its blood 
supply from the lateral circumflex nutrient artery, well 
documented for its reliability and consistency.35–37 Tradi-
tionally, the flap is used for abdominal and trochanteric 
defects,38–41 and generally its use is associated with little 
donor-site morbidity and loss of function. It is reported 
that the “safe dimensions” for the flap extends from the 
pedicle artery to 8–10 cm above the knee and should be 
no wider than 15 cm29,42; however, Saito et al.43 required 
skin grafts to primarily close all 9 donor sites in their study, 
despite the flap being less than 10 cm in some of their 
patients. In our own study, all donor sites were primarily 
closed without the need of skin grafts. Generally, if the 
flap is less than 9 cm wide, the donor site can be closed di-
rectly without the use of a skin graft. Kim et al.39 reported 
on their use of the TFL in coverage of large trochanteric 
pressure sores. A limitation identified in their study was 
the instability of the T junction where the middle of the 
TFL flap met the donor site. Aslan et al.44 reported similar 
findings. In an attempt to avoid wound dehiscence, all 5 
patients in our study were treated with NPWT postopera-
tively to allow splinting of the surgical site at the points of 
inadvertent tension. The TFL flap has been criticized for 
its bulkiness and short vascular pedicle, 2 characteristics 
we use to our advantage.35,36 Like the SM flap, the TFL 
flap is in close proximity to the groin and thus a shorter 
pedicle flap needing minimal rotation can be used, thus 
reducing risk of nerve and pedicle impingement and al-
lowing for primary closure without tension or dog-ear for-
mation. The combination of SM and TFL flaps has several 
advantages. The SM flap provides coverage of the pros-
thetic graft with well-vascularized tissue, whereas the TFL 
flap provides a tension-free and stable wound coverage 
of the groin defect over the SM flap. The TFL flap has a 
strong supporting fascial layer, and the elastic skin of the 
flap tolerates the mobility in the groin far better than a 
skin graft over the SM flap. Another possible advantage 
of the TFL flap could be its contribution on lymphatic 
drainage. Slavin et al.45 showed in an experimental ani-
mal model how muscle transposition restored lymphatic 
continuity and could be used to prevent the development 
of lymphedema. In a series of case reports, Parrett et al.46 
successfully used the contralateral musculocutaneous rec-
tus abdominis flap to treat lower extremity lymphedema. 
Shermak et al.2 reported on the resolution of lymphoceles 
after arterial bypass surgery using different muscle flaps, 
although no TFL flap was used. Microscopic examination 
of a biopsy specimen of a healed gracilis muscle flap taken 
1 year after surgery revealed a histological result consis-
tent with multiple lymphatic channels. The TFL flap in 
our case series could also serve as a conduit for lymph flow 
through the groin. The cutaneous pedicle to the TFL flap 
was left intact to optimize lymph flow through the dermal 
lymphatics.
There are a kaleidoscope of complications associated 
with groin wounds such as cellulitis, hematomas, lymphor-
rhoea, sepsis, and amputation, especially in those with 
comorbidities like diabetes, obesity, smoking history, and 
prosthetic graft reconstruction. With this in mind, it is rea-
sonable to consider preempting such health implications 
and thus saving time and capital and reducing morbidity 
and the need for secondary flap transpositions. In the re-
port by Fischer et al.,47 68 prophylactic muscle flap proce-
dures were performed in 53 patients before complications 
arose and were compared with the rate of complications 
in 195 open vascular groin surgeries in 178 patients. The 
results, although limited by possible selection bias and 
lack of a selection algorithm and randomized trial, reaped 
significant information regarding the procedure. It was 
found that the risk of complications increased 3.5 times 
in patients having reoperative surgery without prophylactic 
flaps, and those undergoing reoperation with a prosthesis 
implant had an increase of 7 times. Similarly, May et al.48 
built on Fischer’s data by qualifying that the early use of 
muscle flap coverage for exposed infected vascular grafts 
improved the rate of graft salvage, with the sartorius being 
described as the best option in prophylactic procedures. 
Lastly, Saito et al.43 described their experience with 3 pa-
tients in their series subjected to wide tumor excision in 
the vicinity of the femoral vessels requiring vascular graft-
ing. A combined TFL pedicle flap was used to recreate the 
soft tissue and skin over the vessels. Two of the patients 
died, 1 on the day following the operation from causes 
unknown and one 20 months after the operation due to 
tumor recurrence and femoral occlusion complicated by 
sepsis. The third patient was followed up 30 months later 
with no reported infection. With these cases in mind, the 
prophylactic use of the combination of SM and TFL flaps 
could be a valuable option in patients with high risk for 
wound complications following an arterial revasculariza-
tion procedure.
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CONCLUSIONS
Our study has some limitations due to its small num-
ber of patients, its retrospective character, and lack of a 
comparative group. Because of the small size, our results 
are indicative and should be interpreted within the con-
text of this limitation. On the other hand, our group of 
patients was a selected group with considerable comor-
bidity and was characterized by having a complex defect 
in the groin with an infected and exposed vascular pros-
thetic graft. Our small series has a mean follow-up of 45 
months, with only 1 recurrence after 15 months. The SM 
and TFL flaps could be used again at the reoperation. 
A larger assessment of the combined use of the sarto-
rius and TFL muscle flaps is needed to expand on our 
ideas and build a more solid argument for their use in 
the clearance of infection and healing of vascular graft 
operation sites.
Louis de Weerd, MD, PhD
Department of Plastic and Reconstructive Surgery
Sykehusveien 38




This study was conducted in compliance with the recognized 
international standards and the principles of the Declaration of 
Helsinki. The information in this article has not been published 
elsewhere in any form.
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